marco falasca
University of Parma
Parma, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Parma
Parma, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
Experimental Research Center, China Academy of Chinese Medical Sciences
Beijing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Chongqing Medical University
Chongqing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Charleston
Charleston, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Oslo
Oslo, Norway
Review Editor
Pharmacology of Anti-Cancer Drugs
Nanjing Normal University
Nanjing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
West China Hospital, Sichuan University
Chengdu, China
Review Editor
Pharmacology of Anti-Cancer Drugs
School of Pharmaceutical Sciences, Sun Yat-sen University
Guangzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
The University of Newcastle
Callaghan, Australia
Review Editor
Pharmacology of Anti-Cancer Drugs
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Review Editor
Pharmacology of Anti-Cancer Drugs
Department of Translational Medicine, University of Eastern Piedmont
Novara, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
Dipartimento di Scienze Cliniche e Medicina Traslazionale, Università di Roma Tor Vergata
Rome, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Milan
Milan, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
Institute of Chemistry, University of São Paulo
São Paulo, Brazil
Review Editor
Pharmacology of Anti-Cancer Drugs
The University of Utah
Salt Lake City, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Santiago de Compostela
Santiago de Compostela, Spain
Review Editor
Pharmacology of Anti-Cancer Drugs